US2018250282A1PendingUtilityA1
Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1
Est. expiryOct 29, 2034(~8.3 yrs left)· nominal 20-yr term from priority
Inventors:Matthew Joseph FisherSteven Lee KuklishPeter Rudolph ManninenKatherine Marie PartridgeMatthew Allen SchifflerAlan M. WarshawskyJeremy Schulenburg York
A61P 43/00A61P 29/00A61P 19/02A61P 19/00A61K 31/00C07D 401/04A61K 31/4709C07D 211/62A61K 31/451C07D 405/14C07D 211/00A61K 31/506A61K 31/4725A61K 31/4545
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salt thereof, where R, R1, and G are as described herein; methods of preparing the compounds; and use of the compounds to treat pain and/or inflammation associated with arthritis or osteoarthritis.
Claims
exact text as granted — not AI-modified1 - 23 . (canceled)
24 . A method of treating a patient in need of treatment for pain or inflammation associated with arthritis or osteoarthritis said method comprising administering to the patient an effective amount of
or a pharmaceutically acceptable salt thereof, in combination with an effective amount of a second agent selected from the group consisting of ibuprofen, aspirin, acetaminophen, celecoxib, naproxen, and ketoprofen.Join the waitlist — get patent alerts
Track US2018250282A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.